Literature DB >> 7828978

Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis.

C D Gillen1, R S Walmsley, P Prior, H A Andrews, R N Allan.   

Abstract

The risk of developing colorectal cancer has been compared in two identically selected cohorts of patients with extensive Crohn's colitis (n = 125) and extensive ulcerative colitis (n = 486). In both groups the effects of selection bias have been reduced wherever possible. There was an 18-fold increase in the risk of developing colorectal cancer in extensive Crohn's colitis and a 19-fold increase in risk in extensive ulcerative colitis when compared with the general population, matched for age, sex, and years at risk. The absolute cumulative frequency of risk for developing colorectal cancer in extensive colitis was 8% at 22 years from onset of symptoms in the Crohn's disease group and 7% at 20 years from onset in the ulcerative colitis group. The relative risk of colorectal cancer was increased in both ulcerative colitis and Crohn's disease among those patients whose colitis started before the age of 25 years. Whether the absolute risk is greater in the younger age group or merely reflects that the expected number of carcinomas increases with age is uncertain. While there is an increased risk of developing colorectal cancer in extensive colitis the number of patients with Crohn's disease who actually develop colorectal cancer is small because many patients with extensive Crohn's colitis undergo colectomy early in the course of their disease to relieve persistent symptoms unresponsive to medical treatment.

Entities:  

Mesh:

Year:  1994        PMID: 7828978      PMCID: PMC1375617          DOI: 10.1136/gut.35.11.1590

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  15 in total

1.  Ulcerative colitis and colorectal cancer. A population-based study.

Authors:  A Ekbom; C Helmick; M Zack; H O Adami
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

Review 2.  Screening for colorectal cancer in ulcerative colitis: dubious benefits and high costs.

Authors:  S Gyde
Journal:  Gut       Date:  1990-10       Impact factor: 23.059

Review 3.  Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review.

Authors:  R H Collins; M Feldman; J S Fordtran
Journal:  N Engl J Med       Date:  1987-06-25       Impact factor: 91.245

4.  Cohort study analysis with a FORTRAN computer program.

Authors:  M Coleman; A Douglas; C Hermon; J Peto
Journal:  Int J Epidemiol       Date:  1986-03       Impact factor: 7.196

5.  Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres.

Authors:  S N Gyde; P Prior; R N Allan; A Stevens; D P Jewell; S C Truelove; R Lofberg; O Brostrom; G Hellers
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

6.  Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982.

Authors:  J H Gollop; S F Phillips; L J Melton; A R Zinsmeister
Journal:  Gut       Date:  1988-01       Impact factor: 23.059

7.  Crohn's disease and carcinoma: increasing justification for surveillance?

Authors:  T J Stahl; D J Schoetz; P L Roberts; J A Coller; J J Murray; M L Silverman; M C Veidenheimer
Journal:  Dis Colon Rectum       Date:  1992-09       Impact factor: 4.585

8.  Increased risk of large-bowel cancer in Crohn's disease with colonic involvement.

Authors:  A Ekbom; C Helmick; M Zack; H O Adami
Journal:  Lancet       Date:  1990-08-11       Impact factor: 79.321

9.  A comparison of cancer risk in Crohn's disease and ulcerative colitis.

Authors:  A J Greenstein; D B Sachar; H Smith; H D Janowitz; A H Aufses
Journal:  Cancer       Date:  1981-12-15       Impact factor: 6.860

10.  Prognosis in Crohn's disease--based on results from a regional patient group from the county of Copenhagen.

Authors:  V Binder; C Hendriksen; S Kreiner
Journal:  Gut       Date:  1985-02       Impact factor: 23.059

View more
  129 in total

1.  Frameshift mutagenesis and microsatellite instability induced by human alkyladenine DNA glycosylase.

Authors:  Joanna Klapacz; Gondichatnahalli M Lingaraju; Haiwei H Guo; Dharini Shah; Ayelet Moar-Shoshani; Lawrence A Loeb; Leona D Samson
Journal:  Mol Cell       Date:  2010-03-26       Impact factor: 17.970

2.  Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation.

Authors:  Hongxia Z Imtiyaz; Emily P Williams; Michele M Hickey; Shetal A Patel; Amy C Durham; Li-Jun Yuan; Rachel Hammond; Phyllis A Gimotty; Brian Keith; M Celeste Simon
Journal:  J Clin Invest       Date:  2010-07-19       Impact factor: 14.808

3.  Surveillance of dysplasia in inflammatory bowel disease: The gastroenterologist-pathologist partnership.

Authors:  David T Rubin; Jerrold R Turner
Journal:  Clin Gastroenterol Hepatol       Date:  2006-11       Impact factor: 11.382

4.  Colorectal cancer and Crohn's colitis: clinical implications from 313 surgical patients.

Authors:  Stefano Scaringi; Carmela Di Martino; Daniela Zambonin; Marilena Fazi; Giuseppe Canonico; Francesca Leo; Ferdinando Ficari; Francesco Tonelli
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

5.  Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium.

Authors:  S Fujii; T Fujimori; H Kawamata; J Takeda; K Kitajima; F Omotehara; T Kaihara; T Kusaka; K Ichikawa; Y Ohkura; Y Ono; J Imura; S Yamaoka; C Sakamoto; Y Ueda; T Chiba
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

6.  Nrf2 is not required for epithelial prohibitin-dependent attenuation of experimental colitis.

Authors:  Arwa S Kathiria; Mackenzie A Butcher; Jason M Hansen; Arianne L Theiss
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-03-14       Impact factor: 4.052

7.  Ulcerative colitis: the fate of the retained rectum.

Authors:  Adam Juviler; Neil Hyman
Journal:  Clin Colon Rectal Surg       Date:  2004-02

8.  Preoperative evaluation and oncologic principles of colon cancer surgery.

Authors:  Matthew L Lynch; Marc I Brand
Journal:  Clin Colon Rectal Surg       Date:  2005-08

Review 9.  Endoscopic and pathological aspects of colitis-associated dysplasia.

Authors:  Fiona D M van Schaik; G Johan A Offerhaus; Marguerite E I Schipper; Peter D Siersema; Frank P Vleggaar; Bas Oldenburg
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-09-22       Impact factor: 46.802

Review 10.  Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways.

Authors:  Aaron J Schetter; Niels H H Heegaard; Curtis C Harris
Journal:  Carcinogenesis       Date:  2009-12-02       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.